Bone Marrow-Derived AXL Tyrosine Kinase Promotes Mitogenic Crosstalk and Cardiac Allograft Vasculopathy
Authors:
Preprint
Abstract
Cardiac Allograft Vasculopathy (CAV) is a leading contributor to late transplant rejection. Although implicated, the mechanisms by which bone marrow-derived cells promote CAV remain unclear. Emerging evidence implicates the cell surface receptor tyrosine kinase AXL to be elevated in rejecting human allografts. AXL protein is found on multiple cell types, including bone marrow-derived myeloid cells. The causal role of AXL from this compartment and during transplant is largely unknown. This is important because AXL is a key regulator of myeloid inflammation. Utilizing experimental chimeras deficient in the bone marrow-derived Axl gene , we report that Axl antagonizes cardiac allograft survival and promotes CAV. Flow cytometric and histologic analyses of Axl -deficient transplant recipients revealed reductions in both allograft immune cell accumulation and vascular intimal thickness. Co-culture experiments designed to identify cell-intrinsic functions of Axl uncovered complementary cell-proliferative pathways by which Axl promotes CAV-associated inflammation. Specifically, Axl- deficient myeloid cells were less efficient at increasing the replication of both antigen-specific T cells and vascular smooth muscle cells (VSMCs), the latter a key hallmark of CAV. For the latter, we discovered that Axl -was required to amass the VSMC mitogen Platelet-Derived Growth Factor. Taken together, our studies reveal a new role for myeloid Axl in the progression of CAV and mitogenic crosstalk. Inhibition of AXL-protein, in combination with current standards of care, is a candidate strategy to prolong cardiac allograft survival.Keywords
All Related Versions
- Published version: The Journal of Heart and Lung Transplantation, 40 (6), 435.
This publication has 37 references indexed in Scilit:
- Treg-mediated suppression of atherosclerosis requires MYD88 signaling in DCsJournal of Clinical Investigation, 2012
- Immune Modulation of Vascular Resident Cells by Axl Orchestrates Carotid Intima-Media ThickeningThe American Journal of Pathology, 2012
- PD-L1 regulates the development, maintenance, and function of induced regulatory T cellsJournal of Experimental Medicine, 2009
- The Axl/Gas6 pathway is required for optimal cytokine signaling during human natural killer cell developmentBlood, 2009
- Divergent Role of Donor Dendritic Cells in Rejection versus Tolerance of AllograftsJournal of the American Society of Nephrology, 2009
- A novel role of CD4 Th17 cells in mediating cardiac allograft rejection and vasculopathyJournal of Experimental Medicine, 2008
- Ex Vivo-Expanded Natural CD4+CD25+ Regulatory T Cells Synergize With Host T-Cell Depletion to Promote Long-Term Survival of AllograftsAmerican Journal of Transplantation, 2008
- TAM Receptors Are Pleiotropic Inhibitors of the Innate Immune ResponseCell, 2007
- Heterotopic vascularized murine cardiac transplantation to study graft arteriopathyNature Protocols, 2007
- Locally acting growth factors for vascular smooth muscle cells: endogenous synthesis and release from platelets.Circulation, 1985